NO985695D0 - Formulation and procedure for treating congestive heart attack - Google Patents

Formulation and procedure for treating congestive heart attack

Info

Publication number
NO985695D0
NO985695D0 NO985695A NO985695A NO985695D0 NO 985695 D0 NO985695 D0 NO 985695D0 NO 985695 A NO985695 A NO 985695A NO 985695 A NO985695 A NO 985695A NO 985695 D0 NO985695 D0 NO 985695D0
Authority
NO
Norway
Prior art keywords
formulation
procedure
congestive heart
heart attack
treating congestive
Prior art date
Application number
NO985695A
Other languages
Norwegian (no)
Other versions
NO985695L (en
Inventor
John L Mcnay
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO985695D0 publication Critical patent/NO985695D0/en
Publication of NO985695L publication Critical patent/NO985695L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO985695A 1996-06-06 1998-12-04 Formulation and procedure for treating congestive heart attack NO985695L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65946396A 1996-06-06 1996-06-06
PCT/US1997/009914 WO1997046241A1 (en) 1996-06-06 1997-06-05 Formulation and method for treating congestive heart failure

Publications (2)

Publication Number Publication Date
NO985695D0 true NO985695D0 (en) 1998-12-04
NO985695L NO985695L (en) 1999-02-04

Family

ID=24645503

Family Applications (1)

Application Number Title Priority Date Filing Date
NO985695A NO985695L (en) 1996-06-06 1998-12-04 Formulation and procedure for treating congestive heart attack

Country Status (17)

Country Link
EP (1) EP0914128A1 (en)
JP (1) JP2000511906A (en)
KR (1) KR20000016406A (en)
CN (1) CN1226166A (en)
AU (1) AU3233197A (en)
BR (1) BR9709546A (en)
CA (1) CA2256720A1 (en)
CZ (1) CZ397698A3 (en)
EA (1) EA199900006A1 (en)
HU (1) HUP0003885A2 (en)
IL (1) IL126966A0 (en)
NO (1) NO985695L (en)
PL (1) PL330637A1 (en)
TR (1) TR199802496T2 (en)
WO (1) WO1997046241A1 (en)
YU (1) YU55998A (en)
ZA (1) ZA974978B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19815411A1 (en) * 1998-04-06 1999-10-07 Solvay Pharm Gmbh Thermogenesis stimulant comprising moxonidine, useful e.g. for treating hypothermia or promoting weight loss, having no cardiac stimulant side effects
AU2727400A (en) * 1999-01-29 2000-08-18 Eli Lilly And Company Moxonidine salts
UA67822C2 (en) * 1999-02-01 2004-07-15 Солвей Фармас'Ютікалс Гмбх Use of moxonidine for treatment of myocardial infarction damages of myocardium, method for producing pharmaceutical composition
EP1894927B1 (en) * 2006-08-31 2010-11-10 Chemagis Ltd. The use of moxonidine salts for purification of moxonidine
KR100812287B1 (en) * 2007-01-03 2008-03-13 주식회사 챠콜코리아 Shade for a traffic signal lamp having reflective layer

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4323570A (en) * 1978-11-15 1982-04-06 Beiersdorf Aktiengesellschaft Substituted aminopyrimidines
DE3617158C2 (en) * 1986-05-22 1994-10-06 Lohmann Therapie Syst Lts Transdermal drug
DE3729299A1 (en) * 1987-09-02 1989-03-23 Beiersdorf Ag TRANSDERMAL THERAPEUTIC SYSTEM
DE3904795C2 (en) * 1989-02-17 2000-10-12 Lilly Pharma Produktion Gmbh & Pharmaceutical preparation and its use
DE4325491A1 (en) * 1993-07-29 1995-02-02 Boehringer Ingelheim Kg Use of centrally acting alpha-2 agonists to inhibit post-aggression metabolism
DE4423177A1 (en) * 1994-07-01 1996-01-04 Kali Chemie Pharma Gmbh Antihyperglycemic drugs
CA2182851A1 (en) * 1995-08-15 1997-02-16 August Masaru Watanabe Method for treating substance abuse withdrawal

Also Published As

Publication number Publication date
HUP0003885A2 (en) 2001-04-28
NO985695L (en) 1999-02-04
CN1226166A (en) 1999-08-18
KR20000016406A (en) 2000-03-25
PL330637A1 (en) 1999-05-24
IL126966A0 (en) 1999-09-22
CZ397698A3 (en) 1999-05-12
CA2256720A1 (en) 1997-12-11
ZA974978B (en) 1998-12-07
WO1997046241A1 (en) 1997-12-11
EP0914128A1 (en) 1999-05-12
YU55998A (en) 1999-11-22
EA199900006A1 (en) 1999-06-24
AU3233197A (en) 1998-01-05
BR9709546A (en) 1999-08-10
TR199802496T2 (en) 1999-02-22
JP2000511906A (en) 2000-09-12

Similar Documents

Publication Publication Date Title
FI973074A0 (en) Baking method and related equipment
NO984431D0 (en) Procedure for treating pain
NO983387D0 (en) Oxygenation apparatus, method of oxygenation of water and use thereof
NO992237D0 (en) Water treatment Process
DE69623437D1 (en) Water treatment apparatus
ITBO960079A0 (en) SOIL TREATMENT EQUIPMENT
ID17194A (en) INFLAMATION TREATMENT METHOD
DK91793A (en) Method of surface treatment, means of application and its use
NO20005433D0 (en) Human BMP-7 promoter and method to explore bone related substance using the same
NO972426D0 (en) Method for the use of triarylethylene derivatives in the treatment and prevention of osteoporosis
DE69718808D1 (en) PLASMA TREATMENT METHOD
NO974153D0 (en) Apparatus for treating curved surfaces
NO984446D0 (en) Procedure for treating pain
NO993030D0 (en) Procedure and system for obtaining connections
IT1285623B1 (en) EQUIPMENT FOR DIALYSIS TREATMENTS
NO985695D0 (en) Formulation and procedure for treating congestive heart attack
DE69717846D1 (en) TREATMENT METHOD OF LACTATAS
NO983215D0 (en) Compositions for treating skin effects and methods for its preparation
ID16924A (en) POLYLELEFIN TREATMENT METHOD
EE9600113A (en) Wastewater treatment method and equipment
NO984906D0 (en) Water treatment
DE29612101U1 (en) Treatment couch
FI972888A0 (en) Water treatment method and equipment and chemical briquette used in the procedure
NO20005432D0 (en) Human BMP-4 promoter and method to explore bone related substance using the same
KR950027501U (en) Water treatment equipment

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application